BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 38261035)

  • 1. First detection of a cefiderocol-resistant and extensively drug-resistant Acinetobacter baumannii clinical isolate in Bulgaria.
    Strateva T; Peykov S
    Acta Microbiol Immunol Hung; 2024 Mar; 71(1):25-36. PubMed ID: 38261035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterisation of cefiderocol-non-susceptible Acinetobacter baumannii isolates from Taiwan.
    Yamano Y; Ishibashi N; Kuroiwa M; Takemura M; Sheng WH; Hsueh PR
    J Glob Antimicrob Resist; 2022 Mar; 28():120-124. PubMed ID: 34958997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induced Heteroresistance in Carbapenem-Resistant
    Mezcord V; Escalante J; Nishimura B; Traglia GM; Sharma R; Vallé Q; Tuttobene MR; Subils T; Marin I; Pasteran F; Actis LA; Tolmasky ME; Bonomo RA; Rao G; Ramirez MS
    Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acinetobacter baumannii response to cefiderocol challenge in human urine.
    Nishimura B; Escalante J; Tuttobene MR; Subils T; Mezcord V; Pimentel C; Georgeos N; Pasteran F; Rodriguez C; Sieira R; Actis LA; Tolmasky ME; Bonomo RA; Ramirez MS
    Sci Rep; 2022 May; 12(1):8763. PubMed ID: 35610334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of Cefiderocol, a Novel Siderophore Cephalosporin, against Multidrug Resistant Acinetobacter baumannii Clinical Isolates in Japan.
    Kimura Y; Hatayama N; Sato Y; Nishida S; Yoshino Y
    Jpn J Infect Dis; 2024 May; 77(3):178-181. PubMed ID: 38296540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotypic and WGS-derived antimicrobial resistance profiles of clinical and non-clinical Acinetobacter baumannii isolates from Germany and Vietnam.
    Wareth G; Linde J; Hammer P; Nguyen NH; Nguyen TNM; Splettstoesser WD; Makarewicz O; Neubauer H; Sprague LD; Pletz MW
    Int J Antimicrob Agents; 2020 Oct; 56(4):106127. PubMed ID: 32750418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activity of cefiderocol against carbapenem-resistant Acinetobacter baumannii carrying various β-lactamase encoding genes.
    Uskudar-Guclu A; Danyildiz S; Mirza HC; Akcil Ok M; Basustaoglu A
    Eur J Clin Microbiol Infect Dis; 2024 Jun; 43(6):1171-1179. PubMed ID: 38652417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genomic Analysis of a Strain Collection Containing Multidrug-, Extensively Drug-, Pandrug-, and Carbapenem-Resistant Modern Clinical Isolates of Acinetobacter baumannii.
    Valcek A; Nesporova K; Whiteway C; De Pooter T; De Coster W; Strazisar M; Van der Henst C
    Antimicrob Agents Chemother; 2022 Sep; 66(9):e0089222. PubMed ID: 35969073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nosocomial Outbreak of Extensively Drug-Resistant Acinetobacter baumannii Isolates Containing
    Hujer AM; Higgins PG; Rudin SD; Buser GL; Marshall SH; Xanthopoulou K; Seifert H; Rojas LJ; Domitrovic TN; Cassidy PM; Cunningham MC; Vega R; Furuno JP; Pfeiffer CD; Beldavs ZG; Wright MS; Jacobs MR; Adams MD; Bonomo RA
    Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28893775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contribution of Iron-Transport Systems and β-Lactamases to Cefiderocol Resistance in Clinical Isolates of Acinetobacter baumannii Endemic to New York City.
    Asrat H; Samaroo-Campbell J; Ata S; Quale J
    Antimicrob Agents Chemother; 2023 Jun; 67(6):e0023423. PubMed ID: 37212653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenotypic and molecular characterization of Acinetobacter baumannii isolates causing lower respiratory infections among ICU patients.
    Jain M; Sharma A; Sen MK; Rani V; Gaind R; Suri JC
    Microb Pathog; 2019 Mar; 128():75-81. PubMed ID: 30562602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Global prevalence of cefiderocol non-susceptibility in Enterobacterales, Pseudomonas aeruginosa, Acinetobacter baumannii, and Stenotrophomonas maltophilia: a systematic review and meta-analysis.
    Karakonstantis S; Rousaki M; Vassilopoulou L; Kritsotakis EI
    Clin Microbiol Infect; 2024 Feb; 30(2):178-188. PubMed ID: 37666449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genomic analysis of extensively drug-resistant Acinetobacter baumannii harbouring a conjugative plasmid containing aminoglycoside resistance transposon TnaphA6.
    Nishida S; Ono Y
    J Infect Public Health; 2024 Feb; 17(2):293-298. PubMed ID: 38150808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deciphering Multidrug-Resistant Acinetobacter baumannii from a Pediatric Cancer Hospital in Egypt.
    Jalal D; Elzayat MG; Diab AA; El-Shqanqery HE; Samir O; Bakry U; Hassan R; Elanany M; Shalaby L; Sayed AA
    mSphere; 2021 Dec; 6(6):e0072521. PubMed ID: 34787450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resistance to Cefiderocol Involved Expression of PER-1 β-Lactamase and Downregulation of Iron Transporter System in Carbapenem-Resistant
    He Y; Wang Y; Ma X; Zhao L; Guan J; Zhao J; Yu W; Li Y; Ni W; Gao Z
    Infect Drug Resist; 2022; 15():7177-7187. PubMed ID: 36514799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High efficacy and enhanced synergistic activity of the novel siderophore-cephalosporin cefiderocol against multidrug-resistant and extensively drug-resistant Klebsiella pneumoniae from inpatients attending a single hospital in the United Arab Emirates.
    Daoud L; Al-Marzooq F; Ghazawi A; Anes F; Collyns T
    J Infect Public Health; 2023 Dec; 16 Suppl 1():33-44. PubMed ID: 37953111
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Abdul-Mutakabbir JC; Nguyen L; Maassen PT; Stamper KC; Kebriaei R; Kaye KS; Castanheira M; Rybak MJ
    Antimicrob Agents Chemother; 2021 Aug; 65(9):e0264620. PubMed ID: 34125590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-Existence of
    Sánchez-Urtaza S; Ocampo-Sosa A; Molins-Bengoetxea A; Rodríguez-Grande J; El-Kholy MA; Hernandez M; Abad D; Shawky SM; Alkorta I; Gallego L
    Int J Mol Sci; 2023 Aug; 24(15):. PubMed ID: 37569889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insight into carbapenem resistance and virulence of Acinetobacter baumannii from a children's medical centre in eastern China.
    Zhu Y; Zhang X; Wang Y; Tao Y; Shao X; Li Y; Li W
    Ann Clin Microbiol Antimicrob; 2022 Nov; 21(1):47. PubMed ID: 36335338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carbapenem-Resistant Acinetobacter baumannii in U.S. Hospitals: Diversification of Circulating Lineages and Antimicrobial Resistance.
    Iovleva A; Mustapha MM; Griffith MP; Komarow L; Luterbach C; Evans DR; Cober E; Richter SS; Rydell K; Arias CA; Jacob JT; Salata RA; Satlin MJ; Wong D; Bonomo RA; van Duin D; Cooper VS; Van Tyne D; Doi Y
    mBio; 2022 Apr; 13(2):e0275921. PubMed ID: 35311529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.